Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2000 1
2001 1
2002 1
2003 3
2004 2
2006 2
2007 5
2008 4
2009 3
2010 4
2012 1
2013 3
2014 3
2015 6
2016 5
2017 7
2018 5
2019 2
2020 2
2021 4
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

55 results

Results by year

Filters applied: . Clear all
Page 1
Martin Leverkus, 1965-2016.
Walczak H, Sprick MR. Walczak H, et al. Among authors: sprick mr. Cell Death Discov. 2017 Jan 23;3:16093. doi: 10.1038/cddiscovery.2016.93. eCollection 2017. Cell Death Discov. 2017. PMID: 28179992 Free PMC article. No abstract available.
Resistance to mesenchymal reprogramming sustains clonal propagation in metastatic breast cancer.
Saini M, Schmidleitner L, Moreno HD, Donato E, Falcone M, Bartsch JM, Klein C, Vogel V, Würth R, Pfarr N, Espinet E, Lehmann M, Königshoff M, Reitberger M, Haas S, Graf E, Schwarzmayr T, Strom TM, Spaich S, Sütterlin M, Schneeweiss A, Weichert W, Schotta G, Reichert M, Aceto N, Sprick MR, Trumpp A, Scheel CH. Saini M, et al. Among authors: sprick mr. Cell Rep. 2023 Jun 27;42(6):112533. doi: 10.1016/j.celrep.2023.112533. Epub 2023 May 30. Cell Rep. 2023. PMID: 37257449 Free article.
Temporal multi-omics identifies LRG1 as a vascular niche instructor of metastasis.
Singhal M, Gengenbacher N, Abdul Pari AA, Kamiyama M, Hai L, Kuhn BJ, Kallenberg DM, Kulkarni SR, Camilli C, Preuß SF, Leuchs B, Mogler C, Espinet E, Besemfelder E, Heide D, Heikenwalder M, Sprick MR, Trumpp A, Krijgsveld J, Schlesner M, Hu J, Moss SE, Greenwood J, Augustin HG. Singhal M, et al. Among authors: sprick mr. Sci Transl Med. 2021 Sep;13(609):eabe6805. doi: 10.1126/scitranslmed.abe6805. Epub 2021 Sep 1. Sci Transl Med. 2021. PMID: 34516824 Free PMC article.
Cancer stem cells--old concepts, new insights.
Vermeulen L, Sprick MR, Kemper K, Stassi G, Medema JP. Vermeulen L, et al. Among authors: sprick mr. Cell Death Differ. 2008 Jun;15(6):947-58. doi: 10.1038/cdd.2008.20. Epub 2008 Feb 15. Cell Death Differ. 2008. PMID: 18259194 Review.
Aggressive PDACs Show Hypomethylation of Repetitive Elements and the Execution of an Intrinsic IFN Program Linked to a Ductal Cell of Origin.
Espinet E, Gu Z, Imbusch CD, Giese NA, Büscher M, Safavi M, Weisenburger S, Klein C, Vogel V, Falcone M, Insua-Rodríguez J, Reitberger M, Thiel V, Kossi SO, Muckenhuber A, Sarai K, Lee AYL, Backx E, Zarei S, Gaida MM, Rodríguez-Paredes M, Donato E, Yen HY, Eils R, Schlesner M, Pfarr N, Hackert T, Plass C, Brors B, Steiger K, Weichenhan D, Arda HE, Rooman I, Kopp JL, Strobel O, Weichert W, Sprick MR, Trumpp A. Espinet E, et al. Among authors: sprick mr. Cancer Discov. 2021 Mar;11(3):638-659. doi: 10.1158/2159-8290.CD-20-1202. Epub 2020 Oct 15. Cancer Discov. 2021. PMID: 33060108 Free PMC article.
Protocol of the IntenSify-Trial: An open-label phase I trial of the CYP3A inhibitor cobicistat and the cytostatics gemcitabine and nab-paclitaxel in patients with advanced stage or metastatic pancreatic ductal adenocarcinoma to evaluate the combination's pharmacokinetics, safety, and efficacy.
Hohmann N, Sprick MR, Pohl M, Ahmed A, Burhenne J, Kirchner M, Le Cornet L, Kratzmann M, Hajda J, Stenzinger A, Steindorf K, Delorme S, Schlemmer HP, Riethdorf S, van Schaik R, Pantel K, Siveke J, Seufferlein T, Jäger D, Haefeli WE, Trumpp A, Springfeld C. Hohmann N, et al. Among authors: sprick mr. Clin Transl Sci. 2023 Dec;16(12):2483-2493. doi: 10.1111/cts.13661. Epub 2023 Nov 3. Clin Transl Sci. 2023. PMID: 37920921 Free PMC article.
Label retaining cells in cancer--the dormant root of evil?
Schillert A, Trumpp A, Sprick MR. Schillert A, et al. Among authors: sprick mr. Cancer Lett. 2013 Nov 28;341(1):73-9. doi: 10.1016/j.canlet.2013.04.019. Epub 2013 Apr 23. Cancer Lett. 2013. PMID: 23624300 Review.
Therapy resistance on the RADar in ovarian cancer.
Schwickert J, Zickgraf FM, Sprick MR. Schwickert J, et al. Among authors: sprick mr. EMBO Mol Med. 2021 May 7;13(5):e14010. doi: 10.15252/emmm.202114010. Epub 2021 Mar 29. EMBO Mol Med. 2021. PMID: 33779077 Free PMC article.
Survival of pancreatic cancer cells lacking KRAS function.
Muzumdar MD, Chen PY, Dorans KJ, Chung KM, Bhutkar A, Hong E, Noll EM, Sprick MR, Trumpp A, Jacks T. Muzumdar MD, et al. Among authors: sprick mr. Nat Commun. 2017 Oct 23;8(1):1090. doi: 10.1038/s41467-017-00942-5. Nat Commun. 2017. PMID: 29061961 Free PMC article.
55 results